These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 959116)

  • 1. Preparation and properties of a novel influenza subunit vaccine.
    Bachmayer H; Liehl E; Schmidt G
    Postgrad Med J; 1976 Jun; 52(608):360-7. PubMed ID: 959116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Postgrad Med J; 1976 Jun; 52(608):373-8. PubMed ID: 785428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody formation in laboratory animals after parenteral application of A/swine influenza virus.
    Dolezalová B; Závadová H; Stárek M; Vonka V
    Dev Biol Stand; 1977 Jun 1-3; 39():405-8. PubMed ID: 604122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 5. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 6. An adsorbed surface-antigen influenza vaccine and its serological activity in volunteers.
    Brady MI; Furminger IG; Stones PB
    Postgrad Med J; 1976 Jun; 52(608):368-72. PubMed ID: 785427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response in four animal species to two different influenza A/swine viruses.
    Dolezalová B; Závadová H; Stárek M; Vonka V
    J Biol Stand; 1978 Jul; 6(3):165-71. PubMed ID: 721835
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influenza vaccination: antibodies against hemagglutinin and neuraminidase after administration of common Al2O3 and Al(OH)3 vaccines in man].
    Kuwert E; Schoop HJ; Marcus I
    Verh Dtsch Ges Inn Med; 1973; 79():1429-33. PubMed ID: 4790204
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of the immune response to influenza virus subunit vaccines.
    Webster RG; Glezen WP; Kasel JA; Laver WG
    Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenicity of recombinant influenza virus vaccines (author's transl)].
    Higashihara M; Suzuki Y; Saito Y; Igarashi Y; Yoshioka I; Takahashi M; Miki Y
    Uirusu; 1979 Dec; 29(2):127-39. PubMed ID: 550564
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of antineuraminidase antibodies and antihemagglutinins in influenza and following administration of live influenza vaccine].
    Nekliudova LI; Fedorova IuB; Orlova NG
    Vopr Virusol; 1974; (2):173-6. PubMed ID: 4446555
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D; Cupo A; Galarza JM
    Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
    Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Formation and protective functions of antibodies to neuraminidase of the influenza A virus].
    Naĭkhin AN; Tsaritsyna IM; Oleĭnikova EV; Ismagulov AT; Reznik VI
    Vopr Virusol; 1985; 30(1):35-9. PubMed ID: 3993000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Test system for detecting and differentiating the influenza virus by an immunoenzyme method].
    Shenderovich SF; Zakstel'skaia LIa; Ivanova VT; Trushinskaia GN; Slepushkin AN
    Vopr Virusol; 1984; 29(4):459-63. PubMed ID: 6388159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous application of influenza chemovaccine and "Vaxigrip" preparations with BCG.
    Zykov MP; Subbotina TI; Rudenko LG; Kaplin NN
    Acta Virol; 1983 Mar; 27(2):160-7. PubMed ID: 6135335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.